- Home
- TRIB vs PPBT Comparison
TRIB vs PPBT Comparison
Compare TRIB & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- PPBT
- Stock Information
- Founded
- TRIB 1992
- PPBT 2010
- Country
- TRIB Ireland
- PPBT Israel
- Employees
- TRIB N/A
- PPBT N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- PPBT Health Care
- Exchange
- TRIB Nasdaq
- PPBT Nasdaq
- Market Cap
- TRIB 5.4M
- PPBT 5.5M
- IPO Year
- TRIB N/A
- PPBT N/A
- Fundamental
- Price
- TRIB $0.98
- PPBT $1.09
- Analyst Decision
- TRIB
- PPBT Strong Buy
- Analyst Count
- TRIB 0
- PPBT 1
- Target Price
- TRIB N/A
- PPBT $33.00
- AVG Volume (30 Days)
- TRIB 120.8K
- PPBT 234.4K
- Earning Date
- TRIB 11-14-2025
- PPBT 11-14-2025
- Dividend Yield
- TRIB N/A
- PPBT N/A
- EPS Growth
- TRIB N/A
- PPBT N/A
- EPS
- TRIB N/A
- PPBT N/A
- Revenue
- TRIB $61,555,000.00
- PPBT N/A
- Revenue This Year
- TRIB $13.51
- PPBT N/A
- Revenue Next Year
- TRIB $13.14
- PPBT N/A
- P/E Ratio
- TRIB N/A
- PPBT N/A
- Revenue Growth
- TRIB 8.31
- PPBT N/A
- 52 Week Low
- TRIB $0.48
- PPBT $0.53
- 52 Week High
- TRIB $3.44
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- TRIB 43.05
- PPBT 72.05
- Support Level
- TRIB $0.88
- PPBT $0.57
- Resistance Level
- TRIB $1.10
- PPBT $0.61
- Average True Range (ATR)
- TRIB 0.07
- PPBT 0.04
- MACD
- TRIB 0.00
- PPBT 0.07
- Stochastic Oscillator
- TRIB 42.19
- PPBT 81.45
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.